Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Corvatta

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|March 8, 2021
Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging TreatmentsMassimo Offidani, Laura Corvatta, Sonia Morè, et al.
Expert Opinion on Investigational Drugs|July 4, 2015
Ixazomib for the treatment of multiple myelomaMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Journal of Hematology|September 9, 2024
Breast Cancer With Release of Tumor Cells in Peripheral Blood Mimicking Acute Myeloid LeukemiaArianna Gatti, Bruno Brando, Irene Cuppari, et al.
Cells|February 25, 2022
Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?Sonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
Expert Opinion on Pharmacotherapy|February 10, 2015
Smoldering multiple myeloma: to treat or not to treatMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Cancer|July 27, 2004
Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort studyMassimo Offidani, Laura Corvatta, Lara Malerba, et al.
European Journal of Haematology|November 29, 2016
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myelomaMassimo Offidani, Laura Corvatta, Sara Bringhen, et al.
Leukemia & Lymphoma|December 29, 2004
Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL)Massimo Offidani, Laura Corvatta, Lara Malerba, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|April 15, 2003
High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemiaMassimo Offidani, Laura Corvatta, Riccardo Centurioni, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Outcome and toxicity in the modern era of new drugs for multiple myeloma: a reappraisal for comparison with future investigational trialsMassimo Offidani, Pietro Leoni, Laura Corvatta, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|March 8, 2021
Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging TreatmentsMassimo Offidani, Laura Corvatta, Sonia Morè, et al.
Expert Opinion on Investigational Drugs|July 4, 2015
Ixazomib for the treatment of multiple myelomaMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Journal of Hematology|September 9, 2024
Breast Cancer With Release of Tumor Cells in Peripheral Blood Mimicking Acute Myeloid LeukemiaArianna Gatti, Bruno Brando, Irene Cuppari, et al.
Cells|February 25, 2022
Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?Sonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
Expert Opinion on Pharmacotherapy|February 10, 2015
Smoldering multiple myeloma: to treat or not to treatMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Cancer|July 27, 2004
Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort studyMassimo Offidani, Laura Corvatta, Lara Malerba, et al.
European Journal of Haematology|November 29, 2016
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myelomaMassimo Offidani, Laura Corvatta, Sara Bringhen, et al.
Leukemia & Lymphoma|December 29, 2004
Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL)Massimo Offidani, Laura Corvatta, Lara Malerba, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|April 15, 2003
High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemiaMassimo Offidani, Laura Corvatta, Riccardo Centurioni, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Outcome and toxicity in the modern era of new drugs for multiple myeloma: a reappraisal for comparison with future investigational trialsMassimo Offidani, Pietro Leoni, Laura Corvatta, et al.
Pageof 5